[HTML][HTML] Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients
VG Hall, VH Ferreira, T Ku, M Ierullo… - … England Journal of …, 2021 - Mass Medical Soc
VG Hall, VH Ferreira, T Ku, M Ierullo, B Majchrzak-Kita, C Chaparro, N Selzner, J Schiff…
New England Journal of Medicine, 2021•Mass Medical SocA Third Vaccine Dose in Organ-Transplant Recipients It is known that people receiving
immune suppressive therapy, such as recipients of solid-organ transplants, have a
suboptimal response to SARS-CoV-2 vaccination. In a randomized, double-blind trial, a third
dose of the mRNA-1273 vaccine was compared with placebo. The third dose of vaccine
produced a significant boost in neutralizing antibodies.
immune suppressive therapy, such as recipients of solid-organ transplants, have a
suboptimal response to SARS-CoV-2 vaccination. In a randomized, double-blind trial, a third
dose of the mRNA-1273 vaccine was compared with placebo. The third dose of vaccine
produced a significant boost in neutralizing antibodies.
A Third Vaccine Dose in Organ-Transplant Recipients
It is known that people receiving immune suppressive therapy, such as recipients of solid-organ transplants, have a suboptimal response to SARS-CoV-2 vaccination. In a randomized, double-blind trial, a third dose of the mRNA-1273 vaccine was compared with placebo. The third dose of vaccine produced a significant boost in neutralizing antibodies.
The New England Journal Of Medicine